Canavan disease is a rare, inherited, neurological disorder. It is characterized by spongy degeneration of the brain. This means the white matter of the brain is replaced by microscopic fluid-filled spaces.Canavan disease may occur in any ethnic group, but it tends to affect persons of Eastern European Jewish ancestry more often.
It is caused by a deficiency of an enzyme called aspartoacylase. Canavan disease is one of a group of genetic disorders called the leukodystrophies. They affect growth of the myelin sheath of the nerve fibers in the brain. The myelin sheath is the fatty covering surrounding nerve cells. It acts as an insulator.
Symptoms of Canavan disease appear in early infancy and progress rapidly. They may include:
Loss of previously acquired movement (motor) skills.
Abnormal muscle tone (floppiness or stiffness).
Poor head control.
Abnormally enlarged head (megalocephaly).
There is no cure for Canavan disease. There is no standard course of treatment either. Treatment is symptomatic and supportive.
The likely outcome (prognosis) for this disease is poor. Death usually happens before age 10.